298 related articles for article (PubMed ID: 12879983)
21. PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease.
Giaccone G; Moda F
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32151109
[TBL] [Abstract][Full Text] [Related]
22. Genetic and infectious prion diseases.
Prusiner SB
Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
[TBL] [Abstract][Full Text] [Related]
23. Chronic wasting disease of elk and deer and Creutzfeldt-Jakob disease: comparative analysis of the scrapie prion protein.
Xie Z; O'Rourke KI; Dong Z; Jenny AL; Langenberg JA; Belay ED; Schonberger LB; Petersen RB; Zou W; Kong Q; Gambetti P; Chen SG
J Biol Chem; 2006 Feb; 281(7):4199-206. PubMed ID: 16338930
[TBL] [Abstract][Full Text] [Related]
24. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.
Cali I; Miller CJ; Parisi JE; Geschwind MD; Gambetti P; Schonberger LB
Acta Neuropathol Commun; 2015 Jun; 3():37. PubMed ID: 26108478
[TBL] [Abstract][Full Text] [Related]
25. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
26. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
27. Cell death signaling in the cerebellum in Creutzfeldt-Jakob disease.
Puig B; Ferrer I
Acta Neuropathol; 2001 Sep; 102(3):207-15. PubMed ID: 11585244
[TBL] [Abstract][Full Text] [Related]
28. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine.
Mishra RS; Basu S; Gu Y; Luo X; Zou WQ; Mishra R; Li R; Chen SG; Gambetti P; Fujioka H; Singh N
J Neurosci; 2004 Dec; 24(50):11280-90. PubMed ID: 15601934
[TBL] [Abstract][Full Text] [Related]
29. BSE: can we predict the future?
Plum J
Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
[TBL] [Abstract][Full Text] [Related]
30. Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.
Caramelli M; Ru G; Acutis P; Forloni G
CNS Drugs; 2006; 20(1):15-28. PubMed ID: 16396521
[TBL] [Abstract][Full Text] [Related]
31. BSE: can we predict the future?
Plum J
Verh K Acad Geneeskd Belg; 1997; 59(5):435-49. PubMed ID: 9490927
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions.
Cescatti M; Saverioni D; Capellari S; Tagliavini F; Kitamoto T; Ironside J; Giese A; Parchi P
J Virol; 2016 Jul; 90(14):6244-6254. PubMed ID: 27122583
[TBL] [Abstract][Full Text] [Related]
33. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
35. Correlation of polydispersed prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric species.
Choi YP; Gröner A; Ironside JW; Head MW
Brain Pathol; 2011 May; 21(3):298-307. PubMed ID: 21029243
[TBL] [Abstract][Full Text] [Related]
36. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
[TBL] [Abstract][Full Text] [Related]
37. Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature.
Rossi M; Saverioni D; Di Bari M; Baiardi S; Lemstra AW; Pirisinu L; Capellari S; Rozemuller A; Nonno R; Parchi P
Acta Neuropathol Commun; 2017 Nov; 5(1):87. PubMed ID: 29169405
[TBL] [Abstract][Full Text] [Related]
38. Spatial correlations between the vacuolation, prion protein (PrPsc) deposits and the cerebral blood vessels in sporadic Creutzfeldt-Jakob disease.
Armstrong RA
Curr Neurovasc Res; 2009 Nov; 6(4):239-45. PubMed ID: 19807656
[TBL] [Abstract][Full Text] [Related]
39. Cerebral amyloidoses: molecular pathways and therapeutic challenges.
Monaco S; Zanusso G; Mazzucco S; Rizzuto N
Curr Med Chem; 2006; 13(16):1903-13. PubMed ID: 16842201
[TBL] [Abstract][Full Text] [Related]
40. Transgenic models of prion disease.
Scott MR; Supattapone S; Nguyen HO; DeArmond SJ; Prusiner SB
Arch Virol Suppl; 2000; (16):113-24. PubMed ID: 11214913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
